Clinuvel Pharmaceuticals | CUV - Ebitda

Stock Price
9.75
Daily Change
-0.08 -0.81%
Monthly
-11.52%
Yearly
-16.02%
Q1 Forecast
9.72

Clinuvel Pharmaceuticals reported AUD27.55M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Avita Medical AUD -9.69M 12.21M Dec/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -20.3M 2.51M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025